This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Biotech Innovator Divine Skin Partners With Giant Ranbaxy To Sell Hair-Growth Treatments

Stocks in this article: DSKX

MIAMI BEACH, Fla., July 18, 2011 /PRNewswire/ -- Biotech pioneer Divine Skin Inc. (DSKX) announced a partnership with India's largest pharmaceutical company, Ranbaxy Laboratories, to sell the DS Laboratories line of topical hair-growth treatments through its massive distribution pipeline.

With its strong presence in the top pharmaceutical markets, Ranbaxy offers Divine Skin an expanded global distribution network. With its innovative line of hair-growth products, Divine Skin offers Ranbaxy several topical formulations proven to work both at the vertex of the scalp and at the hairline, unlike other brands.

"This agreement is a game changer for Divine Skin investors," declared CEO Daniel Khesin. "Ranbaxy is certainly has the resources to develop its own hair-growth brand, yet it has chosen to partner with Divine Skin. It's a powerful endorsement of our cutting-edge technologies. Now our challenge is to accelerate production to keep up with sales."

The DS Laboratories brand expands the treatment options available for men and women suffering hair loss and thinning. Products include the Spectral line of leave-in treatments and the Revita line of shampoo, conditioner, and eyelash treatment.

The comprehensive formulas blend various combinations of minoxidil, finasteride, Aminexil, peptides, procyanidin, stem cells, spin traps, dihydrotestosterone inhibitors, and other powerful ingredients. A proprietary Nanosome delivery system encapsulates active compounds for deeper penetration, longer persistence, and greater efficacy.

About Ranbaxy

Ranbaxy Laboratories is a top-20 pharmaceutical company manufacturing a wide range of high-quality generic medications. Headquartered near New Delhi, the company has global revenue of $1.9 billion, customers in 125 countries, presence in 46 countries, and manufacturing facilities in seven countries.

Already a manufacturing and distribution powerhouse, the company focuses on research and development of innovative drugs for its future growth ( www.Ranbaxy.com).

About Divine Skin

Divine Skin Inc. leads in the development of biotechnology for topical, nutritional, and pharmaceutical therapies. It markets worldwide through online and specialty retailers, cosmetics wholesalers, salons, and medical offices.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs